SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LCSG - T19.com

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jmhollen who started this subject4/2/2002 10:19:06 AM
From: jmhollen   of 9
 
Pickens Group Makes Equity Investment in LCS Golf

WEST PALM BEACH, Fla., Apr 2, 2002 (BW HealthWire) -- Pickens makes investment in LCS Golf (OTC:LCSG).

Pickens Group has purchased 2,000,000 shares of restricted 144 stock for $1,000,000. LCSG will use the proceeds from the equity investment to complete the acquisition of T-19 Incorporated.


Michael O. Pickens, son of T. Boone Pickens and CEO of Pickens Group, said "T-19 is a very exciting acquisition for LCS Golf, and I am very pleased to be part of this transaction. Dr. Michael Mitchell and his team are great to work with and I look forward to an extremely successful expansion of T-19." The Pickens Group invests debt/equity capital in private/public companies and manages the group of M3 hedge funds.

T-19 Inc., will become a wholly owned subsidiary of LCS Golf Inc.

T-19 holds U.S. (http://patft.uspto.gov/netacgi/tubercin) and Foreign patents along with worldwide distribution rights for T-19. (http://www.T-19.com) T-19 is a Nasal Spray comprised of a natural compound called Tubercin (www.tubercin.com). The T-19 Nasal Spray will be marketed worldwide, as an immune stimulant, through traditional retail distribution networks. T-19 may enhance the human immune system and help improve overall health. T-19 is natural and has no known adverse side effects.

Mike Pickens and Dr. Michael D. Mitchell will be working together with LCS to insure the successful future of T-19 Incorporated.

LCS Golf CEO Michael D. Mitchell M.D. stated, "It gives me great satisfaction that the Pickens group believes as strongly as I do in this merger between LCS Golf and T-19 Incorporated (Tubercin). I look forward to working with Mike Pickens and the Pickens Group.

T-19 (Tubercin) is a neutraceuticle product, it is ingested as a nasal spray and helps support a healthy immune system.

The Pickens Group LLC has been very successful in presenting companies to the financial community and this unique opportunity gives LCS Golf, (OTC:LCSG) not only a strong investor but also a very strong circle of influence to open doors as we launch our products," said Dr. Michael Mitchell, CEO of LCS Golf.

Dr. Ronald Shinn, president and CEO of T-19 Incorporation, comments, "With the addition of the Pickens Group we are now a well rounded company and we will be able to move product to market and build a successful company."

CONTACT: T-19 Incorporated, Honolulu Eric Schopfer, 866/523-5800

.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext